High-density lipoprotein levels and risk of cardiovascular events: a review

Gian Francesco Mureddu1, Filippo Brandimarte, Leonardo De Luca

  • 1Echocardiography Laboratory and Cardiovascular Prevention Unit, San Giovanni-Addolorata Community Hospital, Rome, Italy. mureddu.gianfra@gmail.com

Insights

High-density lipoprotein cholesterol (HDL-C) is a key predictor of cardiovascular events, independent of other risk factors. While raising HDL-C shows promise, current treatments lack definitive proof of cardiovascular outcome reduction independent of LDL-C changes.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • High-density lipoprotein cholesterol (HDL-C) is a significant independent predictor of cardiovascular events.
  • The inverse relationship between HDL-C and cardiovascular risk is continuous and independent of factors like blood pressure, smoking, and BMI.
  • Residual cardiovascular risk persists even with low-density lipoprotein cholesterol (LDL-C) below guideline targets, highlighting HDL-C's importance.

Purpose of the Study:

  • To review the role of HDL-C in cardiovascular disease risk.
  • To evaluate the efficacy of treatments aimed at increasing HDL-C levels for cardiovascular event reduction.
  • To identify gaps in current understanding and therapeutic strategies related to HDL-C.

Main Methods:

  • Literature review of studies on HDL-C, cardiovascular risk, and lipid-lowering therapies.
  • Analysis of clinical trial data and epidemiological studies.
  • Evaluation of pharmacological interventions targeting HDL-C.

Main Results:

  • HDL-C levels strongly correlate with atherosclerosis progression and cardiovascular disease risk.
  • Treatments increasing HDL-C have shown potential in reducing cardiovascular disease incidence.
  • Pharmacological evidence for HDL-C-raising therapies independently reducing cardiovascular outcomes is not fully established.

Conclusions:

  • Current guidelines do not target HDL-C levels specifically due to incomplete evidence on independent outcome benefits.
  • Statins have limited impact on HDL-C; fibrates yield inconclusive results; niacin has side effects.
  • Further research is essential to explore novel compounds for raising HDL-C or modifying its function for cardiovascular protection.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...